Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

VitaNova Life Sciences (YJGJ) Equity Ratio (2017 - 2026)

VitaNova Life Sciences (YJGJ) has disclosed Equity Ratio for 8 consecutive years, with 0.81 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio fell 1.17% year-over-year to 0.81, compared with a TTM value of 0.81 through Oct 2025, down 1.17%, and an annual FY2025 reading of 0.85, down 4.44% over the prior year.
  • Equity Ratio was 0.81 for Q4 2025 at VitaNova Life Sciences, down from 0.83 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.9 in Q1 2024 and bottomed at 6.78 in Q2 2023.
  • Average Equity Ratio over 5 years is 0.61, with a median of 0.81 recorded in 2025.
  • The sharpest move saw Equity Ratio tumbled 2474.83% in 2023, then soared 118.14% in 2024.
  • Year by year, Equity Ratio stood at 0.54 in 2021, then plummeted by 59.36% to 0.86 in 2022, then crashed by 689.16% to 6.78 in 2023, then soared by 112.12% to 0.82 in 2024, then dropped by 1.17% to 0.81 in 2025.
  • Business Quant data shows Equity Ratio for YJGJ at 0.81 in Q4 2025, 0.83 in Q3 2025, and 0.85 in Q2 2025.